Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Bioplastics01:27

Bioplastics

70
Bioplastics derived from microbial processes present a sustainable alternative to conventional petroleum-based plastics. Among these, polyhydroxyalkanoates (PHAs), particularly polyhydroxybutyrates (PHBs), have emerged as prominent candidates due to their biodegradability and biocompatibility. These polymers are synthesized by a variety of bacteria, such as Cupriavidus necator and Pseudomonas putida, which naturally accumulate PHAs as intracellular carbon and energy reserves, especially under...
70
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

627
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

4.2K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
4.2K
Teratogenicity01:07

Teratogenicity

4.2K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

151
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
151

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Insights into possibilities for grouping and read-across for nanomaterials in EU chemicals legislation.

Nanotoxicology·2018
Same author

White paper on the promotion of an integrated risk assessment concept in European regulatory frameworks for chemicals.

The Science of the total environment·2015
Same author

Neurodevelopmental and neurobehavioural effects of polybrominated and perfluorinated chemicals: a systematic review of the epidemiological literature using a quality assessment scheme.

Toxicology letters·2014
Same author

With the benefit of hindsight: trials using retrospective controls versus randomized controlled trials in clinical toxicology.

Clinical toxicology (Philadelphia, Pa.)·2013
Same author

Perspectives for integrating human and environmental risk assessment and synergies with socio-economic analysis.

The Science of the total environment·2013
Same author

Feasibility of the extended one-generation reproductive toxicity study (OECD 443).

Reproductive toxicology (Elmsford, N.Y.)·2012

Related Experiment Video

Updated: Apr 29, 2026

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
07:08

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

8.1K

Bisphenol A--Why an adverse outcome pathway framework needs to be applied.

R E FitzGerald1, M F Wilks1

  • 1Swiss Centre for Applied Human Toxicology (SCAHT), University of Basel, Klingelbergstrasse 61, 4056 Basel, Switzerland.

Toxicology Letters
|May 17, 2014
PubMed
Summary

Bisphenol A (BPA) research reveals effects at low doses not detected by standard toxicity tests. The Adverse Outcome Pathway (AOP) framework is proposed to improve risk assessment for endocrine-disrupting chemicals like BPA.

Keywords:
Adverse outcome pathwayBisphenol AHuman health risk assessmentMembrane-bound estrogen receptor

More Related Videos

Assessment of the Effects of Endocrine Disrupting Compounds on the Development of Vertebrate Neural Network Function Using Multi-electrode Arrays
08:28

Assessment of the Effects of Endocrine Disrupting Compounds on the Development of Vertebrate Neural Network Function Using Multi-electrode Arrays

Published on: April 26, 2018

8.8K
Collection of Alfalfa Root Exudates to Study the Impact of Di2-ethylhexyl Phthalate on Metabolite Production
06:46

Collection of Alfalfa Root Exudates to Study the Impact of Di2-ethylhexyl Phthalate on Metabolite Production

Published on: June 2, 2023

2.4K

Related Experiment Videos

Last Updated: Apr 29, 2026

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
07:08

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

8.1K
Assessment of the Effects of Endocrine Disrupting Compounds on the Development of Vertebrate Neural Network Function Using Multi-electrode Arrays
08:28

Assessment of the Effects of Endocrine Disrupting Compounds on the Development of Vertebrate Neural Network Function Using Multi-electrode Arrays

Published on: April 26, 2018

8.8K
Collection of Alfalfa Root Exudates to Study the Impact of Di2-ethylhexyl Phthalate on Metabolite Production
06:46

Collection of Alfalfa Root Exudates to Study the Impact of Di2-ethylhexyl Phthalate on Metabolite Production

Published on: June 2, 2023

2.4K

Area of Science:

  • Environmental Toxicology
  • Endocrinology
  • Chemical Risk Assessment

Background:

  • Bisphenol A (BPA) is a widely used chemical with extensive research.
  • Many studies report adverse effects at doses below regulatory no observed adverse effect levels (NOAELs).
  • The relevance of in vitro and animal findings for human health risk assessment remains debated.

Purpose of the Study:

  • To address the limitations of current regulatory toxicity studies for chemicals like BPA.
  • To advocate for the adoption of structured approaches like the OECD Adverse Outcome Pathway (AOP) framework.
  • To highlight the need for improved hazard characterization and risk assessment methodologies.

Main Methods:

  • Review of existing in vitro and animal studies on Bisphenol A (BPA).
  • Analysis of BPA's mechanism of action, including estrogen receptor interactions.
  • Evaluation of current regulatory toxicology study designs and their limitations.

Main Results:

  • BPA exhibits effects at low, environmentally relevant concentrations (fM-nM) not typically detected in standard regulatory studies.
  • BPA's endocrine-disrupting activity, including estrogen mimicry, can lead to downstream effects like reproductive and developmental abnormalities.
  • Current risk assessment approaches may not adequately capture the full spectrum of BPA's potential hazards.

Conclusions:

  • The Adverse Outcome Pathway (AOP) framework offers a structured approach to designing and evaluating studies for endocrine-disrupting chemicals.
  • Establishing AOPs for BPA and similar chemicals requires significant investment in basic research and stakeholder training.
  • Improved methodologies are crucial for accurate human health risk assessment of widely used chemicals.